We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

28 hedge funds and large institutions have $44.2M invested in Apollo Endosurgery, Inc. in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

135% more capital invested

Capital invested by funds: $18.8M → $44.2M (+$25.4M)

7% less funds holding

Funds holding: 3028 (-2)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.5%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
3
Increased
13
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VBCG
26
Valley Brook Capital Group
Pennsylvania
+$5 +2 New
Wells Fargo
27
Wells Fargo
California
+$50 +19 +29%
Morgan Stanley
28
Morgan Stanley
New York
+$353 +134 +383%

APEN Hedge Fund Activity: Q4 2020 in Review

28 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2020, worth a combined $44.2M — up 135% from $18.8M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of APEN and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 13 added.

The largest buyer was Stonepine Capital Management, adding an estimated $2.37M. The largest seller was University of Texas/Texas AM Investment Management Co (UTIMCO), cutting an estimated $694K.

  • 28 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2020, down from 30 in Q3 2020.
  • Funds reported $44.2M of Apollo Endosurgery, Inc. stock for Q4 2020, up 135% quarter-over-quarter.
  • 3 funds opened new Apollo Endosurgery, Inc. positions in Q4 2020 and 4 closed out, a net change of -1 holder.
  • The largest Apollo Endosurgery, Inc. buyer in Q4 2020 was Stonepine Capital Management, an estimated $2.37M added.
  • The largest Apollo Endosurgery, Inc. seller in Q4 2020 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $694K sold.

Based on aggregated 13F filings for Q4 2020.